MYD88, involved in the Toll-like receptor signaling pathway, is commonly mutated in PCNSL and has been detected in both tumor tissue and CSF (27, 28), potentially reflecting the CNS-specific immune response to the tumor. Here, MYD88 is linked to primary central nervous system lymphoma.